eBook
Digital therapeutics (DTx) deliver evidence-based interventions to patients that are similar to more traditional therapies involving physical interactions with the human body. Compared with traditional pharmaceutical drug development, DTx can be created via quickly iterative and rapidly progressing technology. MedTech firms that manage their DTx-like software with fast feedback loops and a hyper-focus on iteration will greatly increase their odds of success. In this eBook, we delineate the business and societal imperative of following this approach to delivering the full value of DTx.